Gentamicin in the Treatment of Meningitis in Neonates
| Autor: | John M. Leedom, Paul F. Wehrle, Allen W. Mathies, Daniel Ivler, Warren Ws |
|---|---|
| Rok vydání: | 1969 |
| Předmět: |
medicine.medical_specialty
Severe disease Sepsis Enterobacteriaceae Kanamycin Salmonella Klebsiella Pseudomonas Case fatality rate Escherichia coli medicine Humans Immunology and Allergy Meningitis Intensive care medicine Cerebrospinal Fluid Suppuration Acinetobacter business.industry Infant Newborn Proteus medicine.disease Chloramphenicol Infectious Diseases Ampicillin Bacterial meningitis Gentamicin Gentamicins business medicine.drug |
| Zdroj: | Journal of Infectious Diseases. 119:476-480 |
| ISSN: | 1537-6613 0022-1899 |
| Popis: | Bacterial meningitis and "sepsis," confirmed by positive blood cultures when they occur during the first 30 days of life, present perhaps the greatest current challenges to the antimicrobial therapist. As detailed below for meningitis, case fatality rates are high, and the survivors frequently have crippling sequelae. This is true in spite of the fact that many of the patients have no obvious underlying severe disease and should be salvageable. Certainly, the infectious processes are not always promptly controlled by standard antimicrobials, and the over-all case fatality and residua rates leave ample scope for improvement in the results of therapy. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|